• Goldsmiths, University of London Featured Masters Courses
  • University of Oxford Featured Masters Courses
  • University of Edinburgh Featured Masters Courses
  • University of Bristol Featured Masters Courses
  • Jacobs University Bremen gGmbH Featured Masters Courses
  • Swansea University Featured Masters Courses
  • University of Southampton Featured Masters Courses
  • University of Derby Online Learning Featured Masters Courses
Nottingham Trent University Featured Masters Courses
University of Manchester Featured Masters Courses
University of Reading Featured Masters Courses
Leeds Beckett University Featured Masters Courses
University of the West of England, Bristol Featured Masters Courses
"kidney"×
0 miles

Masters Degrees (Kidney)

We have 16 Masters Degrees (Kidney)

  • "kidney" ×
  • clear all
Showing 1 to 15 of 16
Order by 
The Institute of Genetic Medicine brings together a strong team with an interest in clinical and developmental genetics. Our research focuses on the causes of genetic disease at the molecular and cellular level and its treatment. Read more
The Institute of Genetic Medicine brings together a strong team with an interest in clinical and developmental genetics. Our research focuses on the causes of genetic disease at the molecular and cellular level and its treatment. Research areas include: genetic medicine, developmental genetics, neuromuscular and neurological genetics, mitochondrial genetics and cardiovascular genetics.

As a research postgraduate in the Institute of Genetic Medicine you will be a member of our thriving research community. The Institute is located in Newcastle’s Life Science Centre. You will work alongside a number of research, clinical and educational organisations, including the Northern Genetics Service.

We offer supervision for MPhil in the following research areas:

Cancer genetics and genome instability

Our research includes:
-A major clinical trial for chemoprevention of colon cancer
-Genetic analyses of neuroblastoma susceptibility
-Research into Wilms Tumour (a childhood kidney cancer)
-Studies on cell cycle regulation and genome instability

Cardiovascular genetics and development

We use techniques of high-throughput genetic analyses to identify mechanisms where genetic variability between individuals contributes to the risk of developing cardiovascular disease. We also use mouse, zebrafish and stem cell models to understand the ways in which particular gene families' genetic and environmental factors are involved in the normal and abnormal development of the heart and blood vessels.

Complex disease and quantitative genetics

We work on large-scale studies into the genetic basis of common diseases with complex genetic causes, for example autoimmune disease, complex cardiovascular traits and renal disorders. We are also developing novel statistical methods and tools for analysing this genetic data.

Developmental genetics

We study genes known (or suspected to be) involved in malformations found in newborn babies. These include genes involved in normal and abnormal development of the face, brain, heart, muscle and kidney system. Our research includes the use of knockout mice and zebrafish as laboratory models.

Gene expression and regulation in normal development and disease

We research how gene expression is controlled during development and misregulated in diseases, including the roles of transcription factors, RNA binding proteins and the signalling pathways that control these. We conduct studies of early human brain development, including gene expression analysis, primary cell culture models, and 3D visualisation and modelling.

Genetics of neurological disorders

Our research includes:
-The identification of genes that in isolation can cause neurological disorders
-Molecular mechanisms and treatment of neurometabolic disease
-Complex genetics of common neurological disorders including Parkinson's disease and Alzheimer's disease
-The genetics of epilepsy

Kidney genetics and development

Kidney research focuses on:
-Atypical haemolytic uraemic syndrome (aHUS)
-Vesicoureteric reflux (VUR)
-Cystic renal disease
-Nephrolithiasis to study renal genetics

The discovery that aHUS is a disease of complement dysregulation has led to a specific interest in complement genetics.

Mitochondrial disease

Our research includes:
-Investigation of the role of mitochondria in human disease
-Nuclear-mitochondrial interactions in disease
-The inheritance of mitochondrial DNA heteroplasmy
-Mitochondrial function in stem cells

Neuromuscular genetics

The Neuromuscular Research Group has a series of basic research programmes looking at the function of novel muscle proteins and their roles in pathogenesis. Recently developed translational research programmes are seeking therapeutic targets for various muscle diseases.

Stem cell biology

We research human embryonic stem (ES) cells, germline stem cells and somatic stem cells. ES cell research is aimed at understanding stem cell pluripotency, self-renewal, survival and epigenetic control of differentiation and development. This includes the functional analysis of genes involved in germline stem cell proliferation and differentiation. Somatic stem cell projects include programmes on umbilical cord blood stem cells, haematopoietic progenitors, and limbal stem cells.

Pharmacy

Our new School of Pharmacy has scientists and clinicians working together on all aspects of pharmaceutical sciences and clinical pharmacy.

Read less
We invite postgraduate research proposals in a number of disease areas that impact significantly on patient care. We focus on exploring the mechanisms of disease, understanding the ways disease impacts patients’ lives, utilising new diagnostic and therapeutic techniques and developing new treatments. Read more

We invite postgraduate research proposals in a number of disease areas that impact significantly on patient care. We focus on exploring the mechanisms of disease, understanding the ways disease impacts patients’ lives, utilising new diagnostic and therapeutic techniques and developing new treatments.

As a student you will be registered with a University research institute, for many this is the Institute for Cellular Medicine (ICM). You will be supported in your studies through a structured programme of supervision and training via our Faculty of Medical Sciences Graduate School.

We undertake the following areas of research and offer MPhil, PhD and MD supervision in:

Applied immunobiology (including organ and haematogenous stem cell transplantation)

Newcastle hosts one of the most comprehensive organ transplant programmes in the world. This clinical expertise has developed in parallel with the applied immunobiology and transplantation research group. We are investigating aspects of the immunology of autoimmune diseases and cancer therapy, in addition to transplant rejection. We have themes to understand the interplay of the inflammatory and anti-inflammatory responses by a variety of pathways, and how these can be manipulated for therapeutic purposes. Further research theme focusses on primary immunodeficiency diseases.

Dermatology

There is strong emphasis on the integration of clinical investigation with basic science. Our research include:

  • cell signalling in normal and diseased skin including mechanotransduction and response to ultraviolet radiation
  • dermatopharmacology including mechanisms of psoriatic plaque resolution in response to therapy
  • stem cell biology and gene therapy
  • regulation of apoptosis/autophagy
  • non-melanoma skin cancer/melanoma biology and therapy.

We also research the effects of UVR on the skin including mitochondrial DNA damage as a UV biomarker.

Diabetes

This area emphasises on translational research, linking clinical- and laboratory-based science. Key research include:

  • mechanisms of insulin action and glucose homeostasis
  • insulin secretion and pancreatic beta-cell function
  • diabetic complications
  • stem cell therapies
  • genetics and epidemiology of diabetes.

Diagnostic and therapeutic technologies

Focus is on applied research and aims to underpin future clinical applications. Technology-oriented and demand-driven research is conducted which relates directly to health priority areas such as:

  • bacterial infection
  • chronic liver failure
  • cardiovascular and degenerative diseases.

This research is sustained through extensive internal and external collaborations with leading UK and European academic and industrial groups, and has the ultimate goal of deploying next-generation diagnostic and therapeutic systems in the hospital and health-care environment.

Kidney disease

There is a number of research programmes into the genetics, immunology and physiology of kidney disease and kidney transplantation. We maintain close links between basic scientists and clinicians with many translational programmes of work, from the laboratory to first-in-man and phase III clinical trials. Specific areas:

  • haemolytic uraemic syndrome
  • renal inflammation and fibrosis
  • the immunology of transplant rejection
  • tubular disease
  • cystic kidney disease.

The liver

We have particular interests in:

  • primary biliary cirrhosis (epidemiology, immunobiology and genetics)
  • alcoholic and non-alcoholic fatty liver disease
  • fibrosis
  • the genetics of other autoimmune and viral liver diseases

Magnetic Resonance (MR), spectroscopy and imaging in clinical research

Novel non-invasive methodologies using magnetic resonance are developed and applied to clinical research. Our research falls into two categories:

  • MR physics projects involve development and testing of new MR techniques that make quantitative measurements of physiological properties using a safe, repeatable MR scan.
  • Clinical research projects involve the application of these novel biomarkers to investigation of human health and disease.

Our studies cover a broad range of topics (including diabetes, dementia, neuroscience, hepatology, cardiovascular, neuromuscular disease, metabolism, and respiratory research projects), but have a common theme of MR technical development and its application to clinical research.

Musculoskeletal disease (including auto-immune arthritis)

We focus on connective tissue diseases in three, overlapping research programmes. These programmes aim to understand:

  • what causes the destruction of joints (cell signalling, injury and repair)
  • how cells in the joints respond when tissue is lost (cellular interactions)
  • whether we can alter the immune system and ‘switch off’ auto-immune disease (targeted therapies and diagnostics)

This research theme links with other local, national and international centres of excellence and has close integration of basic and clinical researchers and hosts the only immunotherapy centre in the UK.

Pharmacogenomics (including complex disease genetics)

Genetic approaches to the individualisation of drug therapy, including anticoagulants and anti-cancer drugs, and in the genetics of diverse non-Mendelian diseases, from diabetes to periodontal disease, are a focus. A wide range of knowledge and experience in both genetics and clinical sciences is utilised, with access to high-throughput genotyping platforms.

Reproductive and vascular biology

Our scientists and clinicians use in situ cellular technologies and large-scale gene expression profiling to study the normal and pathophysiological remodelling of vascular and uteroplacental tissues. Novel approaches to cellular interactions have been developed using a unique human tissue resource. Our research themes include:

  • the regulation of trophoblast and uNk cells
  • transcriptional and post-translational features of uterine function
  • cardiac and vascular remodelling in pregnancy

We also have preclinical molecular biology projects in breast cancer research.

Respiratory disease

We conduct a broad range of research activities into acute and chronic lung diseases. As well as scientific studies into disease mechanisms, there is particular interest in translational medicine approaches to lung disease, studying human lung tissue and cells to explore potential for new treatments. Our current areas of research include:

  • acute lung injury - lung infections
  • chronic obstructive pulmonary disease
  • fibrotic disease of the lung, both before and after lung transplantation.

Pharmacology, Toxicology and Therapeutics

Our research projects are concerned with the harmful effects of chemicals, including prescribed drugs, and finding ways to prevent and minimise these effects. We are attempting to measure the effects of fairly small amounts of chemicals, to provide ways of giving early warning of the start of harmful effects. We also study the adverse side-effects of medicines, including how conditions such as liver disease and heart disease can develop in people taking medicines for completely different medical conditions. Our current interests include: environmental chemicals and organophosphate pesticides, warfarin, psychiatric drugs and anti-cancer drugs.

Pharmacy

Our new School of Pharmacy has scientists and clinicians working together on all aspects of pharmaceutical sciences and clinical pharmacy.



Read less
Specialize in optimizing company decisions by using data and mathematical models and algorithms. Read more

Course details

Specialize in optimizing company decisions by using data and mathematical models and algorithms
Do you like working with data and mathematics? Do you want to specialize in solving the most complex decision problems, from supply chain management to vehicle routing and from donor kidney allocation to train scheduling? Then Business Analytics and Operations Research is the right program for you.

Apply the theory in practice, and learn to communicate efficiently with decision makers
This program teaches generic Data Science and Optimization methods that allow you to solve decision problems in a wide variety of applications. Examples from logistics include vehicle routing, supply chain optimization, and inventory management. But there are many other applications, such as donor kidney allocation and optimizing tumor treatment plans in the medical field, or dike height optimization and train scheduling in the public sector.

Because Business Analytics and Operations Research are predominantly applied fields, you will also develop the skills to successfully apply the theory in practice, and to communicate efficiently with the decision makers.

The program offers you:

- a degree qualification held in high regard by international organizations that increasingly depend on quantitative methods to support their operations, logistics and supply chain management decision-making.

- a program that is comparable to top Business Analytics and Operations Research programs in the world, both in terms of the contents of the courses and the quality of the teachers and supervisors.

- excellent career perspectives: The Master's program in Business Analytics and Operations Research is one of the programs with the best career prospects. Business Analytics and Operations Research professionals are currently in very high demand, and the demand is predicted to increase even further.

- relevant, real-world learning where the emphasis is on solving actual business problems and turning data into managerial insights, whether it is during in-class exercises or while on an internship in a company.

- BAOR Mastermind, your ideal opportunity to explore the labor market and meet your future employer! We invite companies that give you insight in real business cases. You will also get the opportunity to discuss new trends in Business Analytics and Operations Research with academics and practitioners.

- lectures by teachers and supervisors that are leading experts in this field, with strong links with practice.

- small class-sizes giving you more quality time with approachable and supportive professors and closer interaction with your classmates

Read less
The Department of Oncology and the Department for Continuing Education’s CPD Centre offer a part-time MSc in Experimental Therapeutics that brings together some of Oxford's leading clinicians and scientists to deliver an advanced modular programme designed for those in full-time employment, both in the UK and overseas. Read more
The Department of Oncology and the Department for Continuing Education’s CPD Centre offer a part-time MSc in Experimental Therapeutics that brings together some of Oxford's leading clinicians and scientists to deliver an advanced modular programme designed for those in full-time employment, both in the UK and overseas.

The Programme draws on the world-class research and teaching in experimental therapeutics at Oxford University and offers a unique opportunity to gain an understanding of the principles that underpin clinical research and to translate this into good clinical and research practice.

Visit the website https://www.conted.ox.ac.uk/about/msc-in-experimental-therapeutics

The first deadline for applications is Friday 20 January 2017

If your application is completed by this January deadline and you fulfil the eligibility criteria, you will be automatically considered for a graduate scholarship. For details see: http://www.ox.ac.uk/admissions/graduate/fees-and-funding/graduate-scholarships.

Programme details

The MSc in Experimental Therapeutics is a part-time course consisting of six modules and a research project and dissertation. The programme is normally completed in two to three years. Students are full members of the University of Oxford and are matriculated as members of an Oxford college.

The modules in this programme can also be taken as individual short courses. It is possible to transfer credit from up to three previously completed modules into the MSc programme, if the time elapsed between commencement of the accredited module(s) and registration for the MSc is not more than two years.

Programme modules:

- The Structure of Clinical Trials and Experimental Therapeutics
- Drug Development, Pharmacokinetics and Imaging
- Pharmacodynamics, Biomarkers and Personalised Therapy
- Adverse Drug Reactions, Drug Interactions, and Pharmacovigilance
- How to do Research on Therapeutic Interventions: Protocol Preparation
- Biological Therapeutics

Course aims

The aim of the MSc programme is to provide students with the necessary training and practical experience to enable them to understand the principles that underpin clinical research, and to enable them to translate that understanding into good clinical and research practice.

By the end of the MSc programme, students should understand the following core principles:

- Development, marketing and regulations of drugs
- Pharmaceutical factors that affect drug therapy
- Pharmacokinetics, pharmacogenetics and pharmacodynamics
- Adverse drug reactions, drug interactions, and pharmacovigilance
- Designing phase I, II and III clinical trials for a range of novel therapeutic interventions (and imaging agents).
- Application of statistics to medicine
- Laboratory assays used to support trial end-points
- Use of non-invasive imaging in drug development
- Application of analytical techniques

By the end of the programme, students should be equipped to:

- demonstrate a knowledge of the principles, methods and techniques for solving clinical research problems and translate this into good clinical and research practice
- apply skills gained in techniques and practical experience from across the medical and biological sciences
- develop skills in managing research-based work in experimental therapeutics
- carry out an extended research project involving a literature review, problem specification and analysis in experimental therapeutics and write a short dissertation

Guidance from the UK Royal College of Physician's Faculty of Pharmaceutical Medicine

The Faculty have confirmed that if enrolled for Pharmaceutical Medicine Specialty Training (PMST), trainees may be able to use knowledge provided by Experimental Therapeutics modules to cover aspects of a module of the PMST curriculum. Trainees are advised to discuss this with their Educational Supervisor.

Experimental Therapeutics modules may also be used to provide those pursuing the Faculty's Diploma in Pharmaceutical Medicine (DPM) with the necessary knowledge required to cover the Diploma syllabus. Applicants for the DPM exam are advised to read the DPM syllabus and rules and regulations.

Members of the Faculty of Pharmaceutical Medicine who are registered in the Faculty's CPD scheme can count participation in Experimental Therapeutics modules towards their CPD record. Non-members may wish to obtain further advice about CPD credit from their Royal College or Faculty.

Assessment methods

To complete the MSc, students need to:

Attend the six modules and complete an assessed written assignment for each module.
Complete a dissertation on a topic chosen in consultation with a supervisor and the Course Director.

Dissertation:
The dissertation is founded on a research project that builds on material studied in the taught modules. The dissertation should normally not exceed 15,000 words.

The project will normally be supervised by an academic supervisor from the University of Oxford, and an employer-based mentor.

The following are topics of dissertations completed by previous students on the course:

- The outcomes of non-surgical management of tubal pregnancy; a 6 month study of the South East London population

- Analysis of the predictive and prognostic factors of outcome in a cohort of patients prospectively treated with perioperative chemotherapy for adenocarcinoma of the stomach or of the gastroesophageal junction

- Evolution of mineral and bone disorder in early Chronic Kidney Disease (CKD): the role of FGF23 and vitamin D

- Survey of patients' knowledge and perception of the adverse drug reporting scheme (yellow cards) in primary care

- The predictive role of ERCC1 status in oxaliplatin based Neoadjuvant for metastatic colorectal cancer (CRC) to the liver

- Endothelial Pathophysiology in Dengue - Dextran studies during acute infection

- Literature review of the use of thalidomide in cancer

- An investigation into the phenotypical and functional characteristics of mesenchymal stem cells for clinical application

- Identification of genetic variants that cause capecitabine and bevacizumab toxicity

- Bridging the evidence gap in geriatric medicines via modelling and simulations

Teaching methods

The class-based modules will include a period of preparatory study, a week of intensive face-to-face lectures and tutorials, followed by a period for assignment work. Attendance at modules will be a requirement for study. Some non-classroom activities will be provided at laboratory facilities elsewhere in the University. The course will include taught material on research skills. A virtual learning environment (VLE) will provide between-module support.

The taught modules will include group work, discussions, guest lectures, and interaction and feedback with tutors and lecturers. Practical work aims to develop the students' knowledge and understanding of the subject.

Find out how to apply here - http://www.ox.ac.uk/admissions/graduate/applying-to-oxford

Read less
The World Health Organisation Global Burden of Disease Study has shown that non-communicable chronic disease accounts for ~ 60% of deaths globally. Read more
The World Health Organisation Global Burden of Disease Study has shown that non-communicable chronic disease accounts for ~ 60% of deaths globally. Major contributors include cardiovascular disease, chronic obstructive pulmonary disease and chronic kidney disease. Inflammation is the central driving force in much of this burden of chronic degenerative disease. This MSc course is therefore designed to integrate current cutting-edge research in the fields of molecular and cellular biology and immunology and use this to demonstrate:

- The fundamental processes of inflammation
- The molecular and cellular mechanisms of disease progression that are driven by inflammation

The course is carefully integrated and combines up-to-date practical and theoretical teaching methods to prepare students for careers in postgraduate biomedical research, medicine, and the bio-pharmaceutical industry.

Read less
- https://www.kent.ac.uk/locations/medway/. This programme builds on a very successful in-house training programme implemented by a major pharmaceutical company. Read more

This course will be held at the Medway Campus

- https://www.kent.ac.uk/locations/medway/

This programme builds on a very successful in-house training programme implemented by a major pharmaceutical company.

It was designed and conceived by pharmaceutical industry experts in drug discovery and will be delivered and assessed by experts in this field at the School of Pharmacy.

The MSc covers how fundamental science is applied to the discovery and development of medicines and the main aims are to:

- provide you with the experience of critically appraising the research questions and techniques that are routine in the pharmaceutical industry workplace

- produce graduates trained in the processes by which fundamental science is linked to the design and development of modern medicines

- provide expert preparation for students who wish to pursue a career in drug discovery, or wish to proceed to a PhD.

Visit the website https://www.kent.ac.uk/courses/postgraduate/736/applied-drug-discovery

Duration: One year full-time (campus based), two years part-time (distance learning)

About Medway School of Pharmacy

Medway School of Pharmacy is one of the few regional schools of pharmacy in the UK, a collaboration between the University of Kent and the University of Greenwich.

The impetus for the formation of the Medway School of Pharmacy came from the local community, who recognised the shortage of qualified pharmacists in all branches of the pharmacy profession in Kent.

The School is now recognised as an established school with accreditation from the General Pharmaceutical Council (GPhC) and the Health and Care Professions Council (HCPC). Graduates are employed in health disciplines in Kent and the south-east and more broadly across the UK.

Course structure

This programme is taught as either a classic one year full-time programme with attendance required on Mondays and Tuesdays for 48 weeks plus an additional study day off-campus, or delivered through distance e-learning using an interactive virtual learning environment on a two-year part-time basis.

The programme comprises 60 credits at certificate level, 60 credits at diploma level and 60 credits at Master’s level. You may choose to end your study at any one of these stages.

Modules

The following modules are indicative of those offered on this programme. This list is based on the current curriculum and may change year to year in response to new curriculum developments and innovation. Most programmes will require you to study a combination of compulsory and optional modules. You may also have the option to take modules from other programmes so that you may customise your programme and explore other subject areas that interest you.

Assessment

Assessment is by 100% coursework; including scientific reports, assignments, essays, a research project and portfolio entries.

Programme aims

This programme aims to:

- produce graduates trained in the processes by which fundamental science is linked to the design and development of modern medicines

- teach you an understanding of the drug discovery process

- provide you with expanded training in the biological sciences technical skills that underpin the processes of drug discovery

- provide you with the experience of critically appraising the research questions and techniques they use routinely in the workplace

- develop a variety of postgraduate level intellectual and transferable skills

- equip you with lifelong learning skills necessary to keep abreast of developments in drug discovery

- provide you with opportunities for shared multidisciplinary learning in drug discovery

- give you the experience of undertaking an independent research project

- provide expert preparation for students who wish to pursue and/or further a career in drug discovery, or wish to proceed to a higher degree (PhD) in topics related to the drug discovery process

- provide access to as wide a range of students as practicable irrespective of race, background, gender or physical disability from both within the UK and from overseas.

Research areas

- Chemistry and drug delivery

This group has laboratories with dedicated state-ofthe art drug delivery, nanotechnology, spectroscopy, chromatography and organic synthesis facilities. It brings together researchers in medicinal chemistry and drug design, nanotechnology and materials science, drug delivery and pharmaceutics encouraging a multidisciplinary approach to research. Research covers synthesis and biological evaluation of potential anti-cancer agents, structurebased drug design, QSAR predication of ADMET properties, controlled release, particle engineering, powder technology, pharmaceutical technology, and novel drug delivery systems, with a focus on respiratory drug delivery.

- Biological sciences

This group is housed in recently refurbished laboratories with dedicated state-of-the-art molecular biological, electrophysiological, tissue culture and microscopy facilities. The research is divided into four main themes; infectious diseases and allergy; neuroscience; renal and cardiovascular physiology; and pharmacology. Examples of current work include: investigation of the use of non-pathogenic virus ‘pseudotypes’ to study pathogenic RNA, study of the properties of neuronal potassium channels and their modulation and the development of new therapies for patients that have developed acute kidney injury in collaboration with a major pharmaceutical company.

- Pharmacy practice

This group conducts research in two areas: public health and medicines optimisation, with a particular focus on cardiovascular diseases and mental health. Work in public health includes studies in physical exercise, alcohol, cardiovascular screening and spirometry testing, plus pharmacovigilance. Studies in medicines optimisation include work in dementia, bipolar disorder and stroke, with an emphasis on the patient perspective.

Careers

Graduates who obtain their PhD from Kent or Greenwich are highly sought after by prospective employers, both within the UK and overseas. Destinations for doctoral graduates include university academic departments, research institutes and leading pharmaceutical and biotechnological companies.

The taught postgraduate programmes are designed to promote the continuing professional development by providing sought-after skills. The programmes are beneficial for those who wish to develop their skills and/or to take the next step in their career. While the MSc in Applied Drug Discovery produces elite drug discovery personnel, who can pursue a career in the pharmaceutical industry or academia.

Find out how to apply here - https://www.kent.ac.uk/courses/postgraduate/apply/

Read less
- https://www.kent.ac.uk/locations/medway/. This programme provides general-level hospital pharmacists – registered with the GPhC and working – with the core skills required to provide holistic pharmaceutical care in the practice setting. Read more

This course will be held at the Medway Campus

- https://www.kent.ac.uk/locations/medway/

This programme provides general-level hospital pharmacists – registered with the GPhC and working – with the core skills required to provide holistic pharmaceutical care in the practice setting.

The programme aligns with a nationally agreed pharmacy practitioner development strategy and is the result of a unique collaboration of higher education institutions across London and the south and east of England.

The programme develops your knowledge and skills in clinical pharmacy practice and medicines management. It works on a philosophy of student-centred workplace learning, supported by workbooks and contact days facilitated by experienced pharmacy practitioners. You are expected to take responsibility for managing your learning and achieving the programme objectives. The ethos and culture of the programme is to enhance and develop self-reliance and an adult approach to learning in support of continuing professional development.

Visit the website https://www.kent.ac.uk/courses/postgraduate/737/general-pharmacy-practice

About Medway School of Pharmacy

Medway School of Pharmacy is one of the few regional schools of pharmacy in the UK, a collaboration between the University of Kent and the University of Greenwich.

The impetus for the formation of the Medway School of Pharmacy came from the local community, who recognised the shortage of qualified pharmacists in all branches of the pharmacy profession in Kent.

The School is now recognised as an established school with accreditation from the General Pharmaceutical Council (GPhC) and the Health and Care Professions Council (HCPC). Graduates are employed in health disciplines in Kent and the south-east and more broadly across the UK.

Modules

For more about the structure of this course please visit the Medway School of Pharmacy website (http://www.msp.ac.uk/studying/postgraduate/cert-gen-pharm-pract/index.html).

Assessment

Assessment is by Objective Structure Clinical Examination (OSCE), multiple-choice questions, assignments, literature review, prescribing audit, change management project, and a competency-based portfolio review.

Programme aims

The PCert and PDip aim to:

- enable you to apply appropriate knowledge, skills and attitudes in order to carry out effectively the role of the general pharmacist practitioner within your pharmacy practice base and wider healthcare teams

- enable you to carry out effective consultations with patients respecting their diverse needs and with regard to confidentiality and consent

- enable you to identify, prioritise and resolve complex pharmaceutical care issues

- enable you to apply knowledge of pathophysiology, pharmacology and the clinical use of drugs and therapeutic guidelines to the treatment of common disease states

- enable you to access, gather, interpret, critically evaluate and summarise medicines information

- enable you to monitor the quality of services provided, identify, prioritise and resolve significant medicines management issues and monitor and evaluate outcomes

- enable you to establish population health needs and apply specialist pharmaceutical knowledge to public health issues.

The MSc aims are to:

- investigate a topic in depth

- evaluate current practice or a new service

- publish research and advance knowledge in pharmacy practice

- develop skills you require for the RPS Advanced Pharmacy Framework

- inspire you and others in your workplace to carry out much needed practice research

- support your future career and perhaps to help you explore new career paths.

Research areas

Chemistry and drug delivery
This group has laboratories with dedicated state-ofthe art drug delivery, nanotechnology, spectroscopy, chromatography and organic synthesis facilities. It brings together researchers in medicinal chemistry and drug design, nanotechnology and materials science, drug delivery and pharmaceutics encouraging a multidisciplinary approach to research. Research covers synthesis and biological evaluation of potential anti-cancer agents, structurebased drug design, QSAR predication of ADMET properties, controlled release, particle engineering, powder technology, pharmaceutical technology, and novel drug delivery systems, with a focus on respiratory drug delivery.

Biological sciences
This group is housed in recently refurbished laboratories with dedicated state-of-the-art molecular biological, electrophysiological, tissue culture and microscopy facilities. The research is divided into four main themes; infectious diseases and allergy; neuroscience; renal and cardiovascular physiology; and pharmacology. Examples of current work include: investigation of the use of non-pathogenic virus ‘pseudotypes’ to study pathogenic RNA, study of the properties of neuronal potassium channels and their modulation and the development of new therapies for patients that have developed acute kidney injury in collaboration with a major pharmaceutical company.

Pharmacy practice
This group conducts research in two areas: public health and medicines optimisation, with a particular focus on cardiovascular diseases and mental health. Work in public health includes studies in physical exercise, alcohol, cardiovascular screening and spirometry testing, plus pharmacovigilance. Studies in medicines optimisation include work in dementia, bipolar disorder and stroke, with an emphasis on the patient perspective.

Careers

This programme provides progression for pharmacists towards advanced practitioner status.

Completion of the practice elements of the course leads to the award of the Certificate of Completion of General Pharmacist Training from an accredited training centre.

Find out how to apply here - https://www.kent.ac.uk/courses/postgraduate/apply/

Read less
- https://www.kent.ac.uk/locations/medway/. This programme, approved by the appropriate professional/regulatory bodies, provides a distance learning option for qualification as a non-medical prescriber. Read more

This course will be held at the Medway Campus

- https://www.kent.ac.uk/locations/medway/

This programme, approved by the appropriate professional/regulatory bodies, provides a distance learning option for qualification as a non-medical prescriber.

Eight contact days cover communication and diagnostic skills. Other topics on the syllabus include the legal, policy, professional and ethical aspects of prescribing, plus pharmacology and patient assessment and monitoring.

Visit the website https://www.kent.ac.uk/courses/postgraduate/740/independent-supplementary-prescribing

About Medway School of Pharmacy

Medway School of Pharmacy is one of the few regional schools of pharmacy in the UK, a collaboration between the University of Kent and the University of Greenwich.

The impetus for the formation of the Medway School of Pharmacy came from the local community, who recognised the shortage of qualified pharmacists in all branches of the pharmacy profession in Kent.

The School is now recognised as an established school with accreditation from the General Pharmaceutical Council (GPhC) and the Health and Care Professions Council (HCPC). Graduates are employed in health disciplines in Kent and the south-east and more broadly across the UK.

Course structure

You can take the Master’s programme as a stand-alone PCert in Independent/Supplementary Prescribing, or as one pathway into the Medicines Management programme, by studying prescribing as either the first or second year of the Medicines Management PDip.

On successful completion, the School will notify the appropriate professional/regulatory body that you have qualified as an independent/supplementary prescriber.

Modules

The following modules are indicative of those offered on this programme. This list is based on the current curriculum and may change year to year in response to new curriculum developments and innovation. Most programmes will require you to study a combination of compulsory and optional modules. You may also have the option to take modules from other programmes so that you may customise your programme and explore other subject areas that interest you.

Assessment

Assessment is by Objective Structured Clinical Examination (OSCE), assignments, case-study analysis, multiple-choice questions, short answer paper, narrative based on portfolio entries and attendance at a period of learning in practice.

Programme aims

This programme aims to:

- prepare pharmacists to practice as supplementary prescribers

- prepare nurses and midwives to practice as supplementary/independent prescribers

- develop the knowledge and skills required by an allied health professional to practice as a supplementary prescriber

- meet the standards set by the respective professional or regulatory body as required within the legislative framework.

Research areas

Chemistry and drug delivery
This group has laboratories with dedicated state-ofthe art drug delivery, nanotechnology, spectroscopy, chromatography and organic synthesis facilities. It brings together researchers in medicinal chemistry and drug design, nanotechnology and materials science, drug delivery and pharmaceutics encouraging a multidisciplinary approach to research. Research covers synthesis and biological evaluation of potential anti-cancer agents, structurebased drug design, QSAR predication of ADMET properties, controlled release, particle engineering, powder technology, pharmaceutical technology, and novel drug delivery systems, with a focus on respiratory drug delivery.

Biological sciences
This group is housed in recently refurbished laboratories with dedicated state-of-the-art molecular biological, electrophysiological, tissue culture and microscopy facilities. The research is divided into four main themes; infectious diseases and allergy; neuroscience; renal and cardiovascular physiology; and pharmacology. Examples of current work include: investigation of the use of non-pathogenic virus ‘pseudotypes’ to study pathogenic RNA, study of the properties of neuronal potassium channels and their modulation and the development of new therapies for patients that have developed acute kidney injury in collaboration with a major pharmaceutical company.

Pharmacy practice
This group conducts research in two areas: public health and medicines optimisation, with a particular focus on cardiovascular diseases and mental health. Work in public health includes studies in physical exercise, alcohol, cardiovascular screening and spirometry testing, plus pharmacovigilance. Studies in medicines optimisation include work in dementia, bipolar disorder and stroke, with an emphasis on the patient perspective.

Careers

Graduates who obtain their PhD from Kent or Greenwich are highly sought after by prospective employers, both within the UK and overseas. Destinations for doctoral graduates include university academic departments, research institutes and leading pharmaceutical and biotechnological companies.

The taught postgraduate programmes are designed to promote the continuing professional development by providing sought-after skills. The programmes are beneficial for those who wish to develop their skills and/or to take the next step in their career.

Find out how to apply here - https://www.kent.ac.uk/courses/postgraduate/apply/

Read less
- https://www.kent.ac.uk/locations/medway/. The Medway School of Pharmacy’s innovative postgraduate distance-learning programme in Medicines Management equips healthcare professionals with the skills and knowledge to contribute effectively to medicines management services and to individual drug therapy decisions. Read more

This course will be held at the Medway Campus

- https://www.kent.ac.uk/locations/medway/

The Medway School of Pharmacy’s innovative postgraduate distance-learning programme in Medicines Management equips healthcare professionals with the skills and knowledge to contribute effectively to medicines management services and to individual drug therapy decisions.

The programme emphasises clinical and costeffective prescribing in the context of holistic consideration of patient needs, and one of its pathways offers you the chance to qualify as an independent/supplementary prescriber.

Visit the website https://www.kent.ac.uk/courses/postgraduate/738/medicines-management

About Medway School of Pharmacy

Medway School of Pharmacy is one of the few regional schools of pharmacy in the UK, a collaboration between the University of Kent and the University of Greenwich.

The impetus for the formation of the Medway School of Pharmacy came from the local community, who recognised the shortage of qualified pharmacists in all branches of the pharmacy profession in Kent.

The School is now recognised as an established school with accreditation from the General Pharmaceutical Council (GPhC) and the Health and Care Professions Council (HCPC). Graduates are employed in health disciplines in Kent and the south-east and more broadly across the UK.

Course structure

You can register for the full MSc programme or undertake stand-alone modules. Modules can be put together to form a short course programme. Module length varies from five to 15 credits.

For the PCert, you must complete 60 credits, of which at least 20 must be from core modules. Diploma students must complete 120 credits, of which at least 40 credits must be from core modules. To gain the MSc, you must complete a 60-credit research project, write a dissertation and present the results as a poster.

Modules

The following modules are indicative of those offered on this programme. This list is based on the current curriculum and may change year to year in response to new curriculum developments and innovation. Most programmes will require you to study a combination of compulsory and optional modules. You may also have the option to take modules from other programmes so that you may customise your programme and explore other subject areas that interest you.

Assessment

Assessment includes case study analysis, critical appraisal of literature, assignments including short essays, a research project and dissertation.

Programme aims

This programme aims to:

- equip healthcare professionals with the skills and knowledge to contribute effectively to medicines management services and to individual drug therapy decisions in primary and secondary care.

- enable you to incorporate your learning directly into your workplace and to rise to the challenges presented by the new, patient-centred NHS.

Research areas

- Chemistry and drug delivery

This group has laboratories with dedicated state-ofthe art drug delivery, nanotechnology, spectroscopy, chromatography and organic synthesis facilities. It brings together researchers in medicinal chemistry and drug design, nanotechnology and materials science, drug delivery and pharmaceutics encouraging a multidisciplinary approach to research. Research covers synthesis and biological evaluation of potential anti-cancer agents, structurebased drug design, QSAR predication of ADMET properties, controlled release, particle engineering, powder technology, pharmaceutical technology, and novel drug delivery systems, with a focus on respiratory drug delivery.

- Biological sciences

This group is housed in recently refurbished laboratories with dedicated state-of-the-art molecular biological, electrophysiological, tissue culture and microscopy facilities. The research is divided into four main themes; infectious diseases and allergy; neuroscience; renal and cardiovascular physiology; and pharmacology. Examples of current work include: investigation of the use of non-pathogenic virus ‘pseudotypes’ to study pathogenic RNA, study of the properties of neuronal potassium channels and their modulation and the development of new therapies for patients that have developed acute kidney injury in collaboration with a major pharmaceutical company.

- Pharmacy practice

This group conducts research in two areas: public health and medicines optimisation, with a particular focus on cardiovascular diseases and mental health. Work in public health includes studies in physical exercise, alcohol, cardiovascular screening and spirometry testing, plus pharmacovigilance. Studies in medicines optimisation include work in dementia, bipolar disorder and stroke, with an emphasis on the patient perspective.

Careers

Graduates who obtain their PhD from Kent or Greenwich are highly sought after by prospective employers, both within the UK and overseas. Destinations for doctoral graduates include university academic departments, research institutes and leading pharmaceutical and biotechnological companies.

The taught postgraduate programmes are designed to promote the continuing professional development by providing sought-after skills. The programmes are beneficial for those who wish to develop their skills and/or to take the next step in their career.

Find out how to apply here - https://www.kent.ac.uk/courses/postgraduate/apply/

Read less
This. MRes Cancer Biology. course will give you advanced knowledge of cellular systems. You will learn about the pathogenesis of cancer, cardiovascular disease, diabetes and kidney fibrosis, along with an exploration of current approaches to cancer gene therapy and immunotherapy. Read more

This MRes Cancer Biology course will give you advanced knowledge of cellular systems. You will learn about the pathogenesis of cancer, cardiovascular disease, diabetes and kidney fibrosis, along with an exploration of current approaches to cancer gene therapy and immunotherapy.

Modules

  • Research Methods and Bioethics
  • Research Project
  • Cell Culture and Antibody Technology
  • Biology of Disease

COME VISIT US ON OUR NEXT OPEN DAY!

Visit us on campus throughout the year, find and register for our next open event on http://www.ntu.ac.uk/pgevents.



Read less
Research profile. Read more

Research profile

The Centre for Inflammation Research (CIR) aims to promote the prevention, diagnosis and treatment of inflammatory diseases through interdisciplinary study of the initiation, regulation and resolution of inflammatory responses and provision of an outstanding environment for research training in the field.

CIR investigators aim to characterise and manipulate key control points in inflammation. We focus on:

  • inhibiting the initiation of inflammation by blocking immunologically specific triggers and by modulating cellular and tissue responses to injurious stimuli
  • finding new approaches to promote beneficial regulation of established inflammatory responses so as to limit tissue injury
  • promoting safe resolution of inflammation and restoration of the structure and function of the perturbed tissue

We have particular interest in inflammatory diseases of the lung and kidney but the principles derived will have ready application to inflammatory responses in the liver, bowel, bone/joint and skin. There is also increasing development of research in the CIR into the links between inflammation and cancer.

The Centre was formally established in 1998.

Training and support

Generic training in presentation skills, project management and writing skills is delivered through the University of Edinburgh's transferable skills programme.

Facilities

The CIR is a multidisciplinary team of research groups under the directorship of Professor John Iredale. The CIR consists of more than 180 researchers, is equipped with state-of-the-art apparatus and is supported by external grant funding. The CIR is now located in the purpose-built Queen's Medical Research Institute along with the centres for Reproductive Biology and Cardiovascular Sciences.



Read less
Research profile. The department of Surgery is headed by Professor O James Garden and has an international profile in surgical research. Read more

Research profile

The department of Surgery is headed by Professor O James Garden and has an international profile in surgical research.

Strong research themes include liver injury and regeneration, innate immunity, the role of the macrophage in chronic kidney-graft rejection, foetal liver stem-cell research, cancer inflammation, medical imaging using microbubbles, modification of stress response pathways and aspects of clinical research in hepatobiliary surgery and transplantation.

Facilities

We cater for our wide range of disciplines with extensive facilities and critical investment in order to create the perfect environment for discovery.



Read less
- https://www.kent.ac.uk/locations/medway/. Start. At any time but preferably in September. Our research programme in Pharmacy gives you the integrated, broad-based research training needed to exploit current advances in pharmaceutical and biological sciences and pharmacy practice. Read more

This course will be held at the Medway Campus

- https://www.kent.ac.uk/locations/medway/

Start: At any time but preferably in September

Our research programme in Pharmacy gives you the integrated, broad-based research training needed to exploit current advances in pharmaceutical and biological sciences and pharmacy practice.

Within the school we have a number of home, EU and international postgraduate students who are undertaking doctoral research degrees. Graduates who obtain their PhD from Kent or Greenwich are highly sought after by prospective employers, both within the UK and overseas. Destinations for doctoral graduates include university academic departments, research institutes and leading pharmaceutical and biotechnological companies.

Visit the website https://www.kent.ac.uk/courses/postgraduate/171/pharmacy

About Medway School of Pharmacy

Medway School of Pharmacy is one of the few regional schools of pharmacy in the UK, a collaboration between the University of Kent and the University of Greenwich.

The impetus for the formation of the Medway School of Pharmacy came from the local community, who recognised the shortage of qualified pharmacists in all branches of the pharmacy profession in Kent.

The School is now recognised as an established school with accreditation from the General Pharmaceutical Council (GPhC) and the Health and Care Professions Council (HCPC). Graduates are employed in health disciplines in Kent and the south-east and more broadly across the UK.

Study support

- Postgraduate resources

Postgraduate students have access to all the facilities at the Medway School of Pharmacy, including clinical skills labs and a ‘simulation man’. As the School of Pharmacy is a joint venture between the two universities, students have access to facilities at Kent’s Medway and Canterbury campuses, and the University of Greenwich.

- Dynamic publishing culture

Medway School of Pharmacy has a research culture and as such postgraduate students publish regularly and widely in journals, conference proceedings and books. Among others, they have recently contributed to: International Journal of Pharmacy Practice; Nephron Physiology; Acta Physiologica; Purinergic Signalling; and European Journal of Pharmacology.

- Researcher Development Programme

Kent's Graduate School co-ordinates the Researcher Development Programme for research students, which includes workshops focused on research, specialist and transferable skills. The programme is mapped to the national Researcher Development Framework and covers a diverse range of topics, including subjectspecific research skills, research management, personal effectiveness, communication skills, networking and teamworking, and career management skills

Research areas

The Medway School of Pharmacy houses strong and vibrant research groups that span a range of pharmacy-related areas. Staff have a wealth of research experience, and UK and international links with both industry and academic institutions.

- Chemistry and drug delivery

This group has laboratories with dedicated state-ofthe art drug delivery, nanotechnology, spectroscopy, chromatography and organic synthesis facilities. It brings together researchers in medicinal chemistry and drug design, nanotechnology and materials science, drug delivery and pharmaceutics encouraging a multidisciplinary approach to research. Research covers synthesis and biological evaluation of potential anti-cancer agents, structurebased drug design, QSAR predication of ADMET properties, controlled release, particle engineering, powder technology, pharmaceutical technology, and novel drug delivery systems, with a focus on respiratory drug delivery.

- Biological sciences

This group is housed in recently refurbished laboratories with dedicated state-of-the-art molecular biological, electrophysiological, tissue culture and microscopy facilities. The research is divided into four main themes; infectious diseases and allergy; neuroscience; renal and cardiovascular physiology; and pharmacology. Examples of current work include: investigation of the use of non-pathogenic virus ‘pseudotypes’ to study pathogenic RNA, study of the properties of neuronal potassium channels and their modulation and the development of new therapies for patients that have developed acute kidney injury in collaboration with a major pharmaceutical company.

- Pharmacy practice

This group conducts research in two areas: public health and medicines optimisation, with a particular focus on cardiovascular diseases and mental health. Work in public health includes studies in physical exercise, alcohol, cardiovascular screening and spirometry testing, plus pharmacovigilance. Studies in medicines optimisation include work in dementia, bipolar disorder and stroke, with an emphasis on the patient perspective.

Careers

Graduates who obtain their PhD from Kent or Greenwich are highly sought after by prospective employers, both within the UK and overseas. Destinations for doctoral graduates include university academic departments, research institutes and leading pharmaceutical and biotechnological companies.

Find out how to apply here - https://www.kent.ac.uk/courses/postgraduate/apply/

Read less
Research degrees are ideal for those wishing to study for a PhD and/or those aiming to improve their laboratory and practical skills. Read more

Course summary

Research degrees are ideal for those wishing to study for a PhD and/or those aiming to improve their laboratory and practical skills. Students wishing to study for a PhD must identify a project supervisor with whom they work to develop a project outline.

Key features

-Intensive period of independent laboratory based training

Career opportunities

Possible careers include: academic/research positions; pharmaceutical industry; biotech companies; environmental agencies; entrepreneurship; patent or science communication

The University welcomes research degree applications in the following areas:

-Biochemistry and cell biology
-Biosensors
-Cancer
-Computational biology
-Ecology, conservation and environmental policy
-Environmental biotechnology and sustainability
-Forensic science
-Immunology
-Kidney disease and diabetes
-Metabolic disease
-Microbiology
-Neuroscience
-Pharmacology

Read less
Taught at our Parkgate Road Campus in Chester, this course is designed to give a comprehensive training in the research and analytical skills in cell and molecular biology. Read more
Taught at our Parkgate Road Campus in Chester, this course is designed to give a comprehensive training in the research and analytical skills in cell and molecular biology.

This MRes has been designed to enhance knowledge of recent advancements in cellular and molecular biology, as well as to develop subject-specific practical and analytical skills. In addition, you will gain experience of undertaking an extended period of research (6-7 months), which will aid your career progression as a molecular bio-scientist.

The programme will involve undertaking two core 20 credit taught modules, followed by an extended period of laboratory research, and submission of a Research report and review, 140 credits.

Why Study Cell and Molecular Biology Pathway with us?

Our lecturers range from enthusiastic early career academics through to internationally acknowledged senior researchers. We are actively involved in undertaking innovative research projects using ‘cutting-edge’ approaches, within the field of molecular and cellular life sciences.

Some of our current projects are listed below:
- Environmental toxicology
- Protection against the ageing
- Calcium signalling
- Biochemistry & pharmacology of intracellular Ca2+ transporters
- Stem cells
- Tissue regeneration
- Pathology of bone disease
- Progression of kidney and bladder cancers
- Novel drug delivery systems via nanoparticles and cell penetrating peptides
- Molecular basis of cancer development
- Novel approaches to cancer therapies
- Molecular immunology
- Development of analytical approaches to detect biomarkers of disease

What will I learn?

The MRes will involve undertaking two core 20 credit taught modules which consists of a mixture of lectures, workshops and practical classes in:
- Advances in Cell and Molecular Biology (BI7144)
- Skills for Molecular and Cellular Bioscientists (BI7145)

Followed by an extended period of laboratory research (140 credits) in an area that allies with the interests of our academic staff.

How will I be taught?

The two taught modules will each comprise of a series of lectures, small group discussion sessions, workshops and practical classes. Nominally each taught module has about 30-40 of contact hours associated with them. The rest of the time allocated for these modules will be for further reading, coursework preparation and revision.

The remainder of the programme will comprise of the 6 to 7 month research project which will involve regular meetings and guidance with your research supervisor. This is followed by the preparation of two reports.

How will I be assessed?

The research dissertation will be assessed by the production of a research report in the format of a scientific paper and a research review (80%).

The taught modules will be assessed by the production of practical and theoretical reports and class tests (20%).

Postgraduate Visit Opportunities

If you are interested in this courses we have a number of opportunities to visit us and our campuses. To find out more about these options and to book a visit, please go to: https://www1.chester.ac.uk/study/postgraduate/postgraduate-visit-opportunities

Request a Prospectus

If you would like to know more about the University please request a prospectus at: http://prospectus.chester.ac.uk/form.php

Read less

Show 10 15 30 per page



Cookie Policy    X